Archives of Medical Sciences. Atherosclerotic Diseases最新文献

{"title":"Evaluation of infrared thermography with a portable camera as a diagnostic tool for peripheral arterial disease of the lower limbs compared with color Doppler ultrasonography.","authors":"Mauro de Deus Passos,&nbsp;Adson Ferreira da Rocha","doi":"10.5114/amsad/150716","DOIUrl":"https://doi.org/10.5114/amsad/150716","url":null,"abstract":"<p><strong>Introduction: </strong>We aimed to evaluate whether infrared thermography (IRT) with a portable camera is a useful tool for diagnosing or screening peripheral arterial disease of the lower limbs (PAD-LL) when compared with the traditional method of color Doppler ultrasonography.</p><p><strong>Material and methods: </strong>The study enrolled 90 volunteers: 45 who were diagnosed with PAD-LL (PAD-LL group) and 45 who did not have a diagnosis of PAD-LL (control group). The diagnosis was made using color Doppler ultrasonography, and the results were compared with those of IRT.</p><p><strong>Results: </strong>The IRT-based procedure evaluated in this study had a sensitivity of 97.62% and a specificity of 91.67% for PAD-LL diagnosis compared to color Doppler ultrasonography. The method was limited for diagnosing PAD-LL manifesting above the knees (suprapopliteal PAD-LL). Our results also suggest that the ankle-brachial index is an important predictor of PAD-LL, with a sensitivity of 91.17% and a specificity of 75% at a value of ≤ 0.9. Current or previous smoking habits, higher body mass index, and the presence of diabetes mellitus were significantly elevated in the PAD-LL group.</p><p><strong>Conclusions: </strong>Our results indicate that IRT is an efficient and low-cost method for screening and diagnosing PAD-LL, particularly infrapopliteal PAD-LL manifesting below the knees. However, further studies are required to establish the validity of this technique.</p>","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2c/60/AMS-AD-7-150716.PMC9487801.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33483742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Therapeutic versus prophylactic heparin for thromboprophylaxis in patients with COVID-19: weighing the costs and benefits. A rapid meta-analysis of randomized controlled trials.","authors":"Athina Dimosiari,&nbsp;Dimitrios Patoulias","doi":"10.5114/amsad/150507","DOIUrl":"https://doi.org/10.5114/amsad/150507","url":null,"abstract":"Corresponding author: Dr. Dimitrios Patoulias Second Propedeutic Department of Internal Medicine Aristotle University of Thessaloniki General Hospital “Hippokration” Thessaloniki, Greece Phone: +30 6946900777 E-mail: dipatoulias@gmail.com 1Department of Emergency Medicine, General Hospital “Mamatsion”, Kozani, Greece 2 Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital “Hippokration”, Thessaloniki, Greece","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/72/90/AMS-AD-7-150507.PMC9487802.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33483253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Role of atrial natriuretic peptide receptor in inhibition of laterally spreading tumors via Wnt/β-catenin signaling.","authors":"Xiaoying Zhang, Qiang Wang, Chengyou Jia, Dan Li, Zhongwei Lv, Jianshe Yang","doi":"10.5114/amsad/151928","DOIUrl":"10.5114/amsad/151928","url":null,"abstract":"<p><p>Colorectal cancer (CRC) is the third most prevalent malignancy worldwide. Laterally spreading tumors (LSTs), as special manifestations of digestive tract tumors, are often misdiagnosed or undiagnosed due to their unique morphological and pathological features. LST has no protruding lesions and progresses rapidly, and prognoses are consequently poor. LST progression to CRC is complicated. Clinical data indicate that the heart is rarely the site of primary tumorigenesis, and a class of atrial natriuretic peptides (ANPs) secreted by heart tissue play an important role in this phenomenon, which is closely related to the Wnt/β-catenin signaling pathway. However, previous studies focused solely on correlations between the Wnt/β-catenin signaling pathway, downstream gene expression and LST. Thus, correlational studies of ANP/ANP receptor, LST and CRC may be of great help in understanding the occurrence, development and treatment of LST, as well as in establishing specific and sensitive methods for detecting LST.</p>","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7c/67/AMS-AD-7-151928.PMC9487803.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33483248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diabetic foot disease during the COVID-19 pandemic: lessons learned for our future.","authors":"Cesare Miranda,&nbsp;Giorgio Zanette,&nbsp;Roberto Da Ros","doi":"10.5114/amsad/151047","DOIUrl":"https://doi.org/10.5114/amsad/151047","url":null,"abstract":"<p><p>The COVID-19 pandemic has had a strong impact on the treatment of all diseases, especially chronic ones, and diabetic foot is no exception. The COVID-19 pandemic has favored the adoption of a new model of assistance delivery to facilitate the delivery of remote assistance to patients. The standard model based on face-to-face visits has been integrated by a hybrid model of telemedicine, home care and face-to-face visits to keep patients at home to minimize the number of in-person visits to clinics and admissions except for complicated DFUs. However, telemedicine is not always possible or suitable for various reasons (patients not digital, need for practical treatment of the foot etc.). In this review, we looked at the different approaches to diabetic foot ulcer management and the indirect impact of the COVID-19 pandemic on diabetes-related lower extremity complications and the lessons we have learned for the future.</p>","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f9/1e/AMS-AD-7-151047.PMC9487836.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33483250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pioglitazone in diabetic kidney disease: forgotten but not gone.","authors":"Georgios S Papaetis","doi":"10.5114/amsad/151046","DOIUrl":"https://doi.org/10.5114/amsad/151046","url":null,"abstract":"<p><p>Diabetic kidney disease (DKD) is described in approximately 20-40% of all diabetic patients and is associated with significant cardiovascular and all-cause mortality. The involvement of multiple metabolic, haemodynamic, inflammatory, and tubular pathways in the pathophysiology of DKD generates the need for multitargeted treatment approaches to improve its development at all levels and delay or even reverse its progression. Thiazolidinediones are potent exogenous agonists of PPAR-γ, which augment the effects of insulin on its cellular targets, mainly at the level of adipose tissue. Pioglitazone, currently the main thiazolidinedione in clinical practice, has achieved significant improvements of albuminuria in patients with type 2 diabetes. It can also interfere with most cellular pathways involved in the development and evolution of DKD. This paper explores the pathophysiological mechanisms governing its possible nephroprotective activity during a diabetic state. It also discusses its future role to ameliorate the global burden of DKD.</p>","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/03/1d/AMS-AD-7-151046.PMC9487837.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33483740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An insertion mutation in the <i>Apoe</i> gene associated with spontaneous hyperlipidemia in mice.","authors":"Hitoshi Hatakeyama,&nbsp;Ichiro Yoshioka,&nbsp;Takeshi Ohsawa,&nbsp;Yoshibumi Matsushima,&nbsp;Kazuhiko Kotani,&nbsp;Shuichi Tsuchida","doi":"10.5114/amsad/150872","DOIUrl":"https://doi.org/10.5114/amsad/150872","url":null,"abstract":"<p><strong>Introduction: </strong>Spontaneously hyperlipidemic (SHL) mice, a mouse strain derived from an inbred strain of Japanese wild (original)-type mice (KOR; <i>Mus musculus molossinus</i>), show high plasma cholesterol concentrations with disruption of the apolipoprotein E (<i>Apoe</i>) gene. However, the details of the <i>Apoe</i> gene of SHL mice have yet to be described.</p><p><strong>Material and methods: </strong>The DNA sequence of the <i>Apoe</i> gene of SHL mice was compared to that of control KOR mice in genomic DNA and cDNA analyses.</p><p><strong>Results: </strong>In the DNA analysis, a 4700-bp fragment was found to be inserted into exon 4 of the <i>Apoe</i> gene of SHL mice. The insertion contained two 365-bp repeats at each terminal and was flanked by a 6-bp target duplication at each side. The inserted fragment produced a frameshift of an early stop codon, resulting in a protein product that consisted of 87 amino acids in SHL mice compared to 311 amino acids in control KOR mice.</p><p><strong>Conclusions: </strong>These findings provide useful information about the molecular basis of SHL mice and related lipid disorders.</p>","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7d/55/AMS-AD-7-150872.PMC9487799.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33483737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical variables for predicting type-1 and type-2 non-ST segment elevation myocardial infarction in those presenting with ischemic symptoms.","authors":"Edward T Ha,&nbsp;Brandon Ng,&nbsp;Abeer Afshaq,&nbsp;Eitan Fleischman,&nbsp;Batool Hosain,&nbsp;Roohi Sharma,&nbsp;Theodore J Gaeta,&nbsp;Manish Parikh,&nbsp;Stephen J Peterson,&nbsp;Wilbert S Aronow","doi":"10.5114/amsad/149921","DOIUrl":"https://doi.org/10.5114/amsad/149921","url":null,"abstract":"<p><strong>Introduction: </strong>The accuracy of detecting myocardial infarction (MI) has greatly improved with the advent of more sensitive assays, and this has led to etiologic subtyping. Distinguishing between type 1 and type 2 non-ST-segment elevation myocardial infarction (NSTEMI) early in the clinical course allows for the most appropriate advanced diagnostic procedures and most efficacious treatments. The purpose of this study was to investigate the predictive effect of demographic and clinical variables on predicting NSTEMI subtypes in patients presenting with ischemic symptoms.</p><p><strong>Material and methods: </strong>We performed a single institution retrospective cohort study of patients who presented to the emergency department (ED) with ischemic signs and symptoms consistent with non-ST-segment myocardial infarction, for whom results of coronary angiography were available. We analyzed demographic, laboratory, echocardiography and angiography data to determine predictors of NSTEMI sub-types.</p><p><strong>Results: </strong>Five hundred and forty-six patients were enrolled; 426 patients were found on coronary angiography to have type 1 acute MI (T1AMI), whereas 120 patients had type 2 acute MI (T2AMI). Age (OR per year = 1.03 (1.00, 1.05), <i>p</i> = 0.03), prior MI (OR = 3.50 (1.68, 7.22), <i>p</i> = 0.001), L/H > 2.0 (OR = 1.55 (1.12, 2.13), <i>p</i> = 0.007), percentage change in troponin I > 25% (OR = 2.54 (1.38, 4.69), <i>p</i> = 0.003), and regional wall motion abnormalities (RWMA) (OR = 3.53 (1.46, 8.54), <i>p</i> = 0.004) were independent predictors of T1AMI, whereas sex, race, body mass index, hypertension, end-stage renal disease (ESRD), heart failure, family history (FH) of coronary artery disease (CAD), HbA_1c, and left ventricular ejection fraction (LVEF) were not.</p><p><strong>Conclusions: </strong>Key clinical variables such as age, prior MI, L/H ratio, percentage change in troponin I, and presence of RWMA on echocardiogram may be utilized as significant predictors of T1AMI in patients presenting with ischemic symptoms to the ED.</p>","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/63/a7/AMS-AD-7-149921.PMC9278173.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40623924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Oxidised high-density lipoprotein in sarcopenia: a pilot study.","authors":"Kazuhiko Kotani,&nbsp;Akihiro Saitsu","doi":"10.5114/amsad.2022.116664","DOIUrl":"https://doi.org/10.5114/amsad.2022.116664","url":null,"abstract":"","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1a/72/AMS-AD-7-149920.PMC9278172.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40513389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Drug-eluting versus nondrug peripheral vascular interventions.","authors":"Tariq Enezate,&nbsp;Anandbir Singh Bath,&nbsp;Viswanatha Chinta,&nbsp;Jad Omran","doi":"10.5114/amsad.2022.116658","DOIUrl":"https://doi.org/10.5114/amsad.2022.116658","url":null,"abstract":"<p><strong>Introduction: </strong>Drug-eluting (DRUG) peripheral vascular interventions (PVIs) are associated with higher patency rates than nondrug (NONDRUG) PVIs. Recent data raised safety concerns with using DRUG devices in PVIs.</p><p><strong>Material and methods: </strong>The study population was extracted from the 2016 Nationwide Readmissions Database using the International Classification of Diseases, tenth edition, clinical modifications/procedure coding system codes for PVI, DRUG and NONDRUG devices, and in-hospital procedural complications. Study endpoints included in-hospital all-cause mortality, length of index hospitalization, acute kidney injury (AKI), amputation, compartment syndrome, vascular complications, bleeding, and blood transfusion. Propensity matching was used to adjust for baseline characteristics.</p><p><strong>Results: </strong>49,883 discharged patients who underwent lower extremity arterial PVI were identified, 25.3% DRUG and 74.7% NONDRUG PVI. Mean age was 68.3 years and 40.6% were female. Critical limb ischemia was reported in 33.2%, claudication in 7.6%, and acute limb ischemia in 0.1%. In comparison to the NONDRUG group, the DRUG group was associated with lower in-hospital all-cause mortality (2.2 vs. 2.9%, <i>p</i> < 0.001), shorter length of index hospitalization (8.3 vs. 8.6 days, <i>p</i> = 0.001), bleeding (12.0% vs. 13.5%, <i>p</i> < 0.001), and need for blood transfusion (10.1% vs. 11.0%, <i>p</i> = 0.004). There was no significant difference in terms of AKI (17.3% vs. 18.0%, <i>p</i> = 0.10), amputation (15.3% vs. 15.4%, <i>p</i> = 0.63), compartment syndrome (0.5% vs. 0.6%, <i>p</i> = 0.07), or vascular complications (0.8% vs. 0.8%, <i>p</i> = 0.50). After propensity matching, the mortality benefit was no longer present.</p><p><strong>Conclusions: </strong>DRUG PVI was associated with lower in-hospital all-cause mortality, bleeding events and shorter length of index hospitalization and comparable vascular-related complications. However, this mortality benefit was no longer present after propensity matching.</p>","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/28/44/AMS-AD-7-150086.PMC9278168.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40623923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of eosinophil-to-lymphocyte ratio with coronary slow-flow phenomenon in patients undergoing coronary angiography.","authors":"Aydın Rodi Tosu,&nbsp;Muhsin Kalyoncuoğlu,&nbsp;Halil İbrahim Biter,&nbsp;Sinem Çakal,&nbsp;Beytullah Çakal,&nbsp;Murat Selçuk,&nbsp;Tufan Çinar","doi":"10.5114/amsad.2022.116662","DOIUrl":"https://doi.org/10.5114/amsad.2022.116662","url":null,"abstract":"<p><strong>Introduction: </strong>The current investigation intended to evaluate the correlation between eosinophil-to-lymphocyte ratio (ELR) and the coronary slow-flow phenomenon (CSFP) in patients undergoing elective coronary angiography.</p><p><strong>Material and methods: </strong>A case-control investigation was conducted on 200 individual CSFP patients and another 200 individuals with normal coronary arteries and who were matched for age, gender, and body mass index. ELR was computed by dividing the number of eosinophils by the number of lymphocytes. Thrombolysis in myocardial infarction frame count was used to determine the CSFP.</p><p><strong>Results: </strong>The ELR in the CSFP group was substantially greater than in the control group [0.38 (0.28-0.50)] and [0.22 (0.17-0.35)], <i>p</i> < 0.001, respectively). With the help of multivariable logistic regression analysis, ELR independently predicted the CSFP presence (odds ratio = 1.040, 95% CI: 1.026-1.053), <i>p</i> < 0.001). The effective cutoff point of ELR in predicting CSFP presence was > 0.29 with sensitivity of 77% and specificity of 70%. ELR had better diagnostic accuracy to predict CSFP than either lymphocyte or eosinophil count alone [AUC = 0.746 vs. AUC = 0.687 vs. AUC = 0.687, respectively].</p><p><strong>Conclusions: </strong>To our knowledge, this was the first investigation to determine the connection between ELR and CSFP. We discovered that individuals with CSFP had higher ELR than those with normal coronary arteries in the control group.</p>","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f9/a2/AMS-AD-7-149923.PMC9278170.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40513388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}